Specific genetic variations in CYP1A1 and CYP1B1 genes were found to be more prevalent in certain cancer patients compared with the control group, suggesting that these polymorphisms might contribute to an increased susceptibility to cancer [222,223,224]. This evidence concerns the gene CYP1B1 and cancer.